- Home
- NSA vs MRUS Comparison
NSA vs MRUS Comparison
Compare NSA & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSA
- MRUS
- Stock Information
- Founded
- NSA 2013
- MRUS 2003
- Country
- NSA United States
- MRUS Netherlands
- Employees
- NSA N/A
- MRUS N/A
- Industry
- NSA Real Estate Investment Trusts
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- NSA Real Estate
- MRUS Health Care
- Exchange
- NSA Nasdaq
- MRUS Nasdaq
- Market Cap
- NSA 3.2B
- MRUS 2.9B
- IPO Year
- NSA 2015
- MRUS 2016
- Fundamental
- Price
- NSA $37.87
- MRUS $41.85
- Analyst Decision
- NSA Hold
- MRUS Strong Buy
- Analyst Count
- NSA 8
- MRUS 12
- Target Price
- NSA $44.36
- MRUS $87.92
- AVG Volume (30 Days)
- NSA 671.3K
- MRUS 670.1K
- Earning Date
- NSA 10-30-2024
- MRUS 10-31-2024
- Dividend Yield
- NSA 6.03%
- MRUS N/A
- EPS Growth
- NSA 71.81
- MRUS N/A
- EPS
- NSA 1.83
- MRUS N/A
- Revenue
- NSA $786,922,000.00
- MRUS $35,932,000.00
- Revenue This Year
- NSA N/A
- MRUS N/A
- Revenue Next Year
- NSA $1.43
- MRUS $57.37
- P/E Ratio
- NSA $20.71
- MRUS N/A
- Revenue Growth
- NSA N/A
- MRUS N/A
- 52 Week Low
- NSA $34.50
- MRUS $26.69
- 52 Week High
- NSA $49.44
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- NSA 25.24
- MRUS 39.11
- Support Level
- NSA $37.18
- MRUS $41.03
- Resistance Level
- NSA $43.88
- MRUS $45.25
- Average True Range (ATR)
- NSA 1.03
- MRUS 2.21
- MACD
- NSA -0.63
- MRUS 0.02
- Stochastic Oscillator
- NSA 9.06
- MRUS 10.15
About NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, Northwest and Move It brands.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.